The prognostic value of methylation signatures and NF2 mutations in atypical meningiomas

Background: Due to the solely subjective histopathological assessment, the WHO 2016 classification of human meningiomas is subject to interobserver variation. Consequently, the need for more reliable and objective markers are highly needed. The aim of this pilot study was to apply genome-wide DNA me...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Meta, Rahmina (VerfasserIn) , Boldt, Henning B. (VerfasserIn) , Kristensen, Bjarne W. (VerfasserIn) , Sahm, Felix (VerfasserIn) , Sjursen, Wenche (VerfasserIn) , Torp, Sverre H. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 12 March 2021
In: Cancers
Year: 2021, Jahrgang: 13, Heft: 6, Pages: 1-13
ISSN:2072-6694
DOI:10.3390/cancers13061262
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers13061262
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/13/6/1262
Volltext
Verfasserangaben:Rahmina Meta, Henning B. Boldt, Bjarne W. Kristensen, Felix Sahm, Wenche Sjursen and Sverre H. Torp

MARC

LEADER 00000caa a2200000 c 4500
001 1756261148
003 DE-627
005 20220819185605.0
007 cr uuu---uuuuu
008 210428s2021 xx |||||o 00| ||eng c
024 7 |a 10.3390/cancers13061262  |2 doi 
035 |a (DE-627)1756261148 
035 |a (DE-599)KXP1756261148 
035 |a (OCoLC)1341407232 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Meta, Rahmina  |e VerfasserIn  |0 (DE-588)1238084923  |0 (DE-627)1765289424  |4 aut 
245 1 4 |a The prognostic value of methylation signatures and NF2 mutations in atypical meningiomas  |c Rahmina Meta, Henning B. Boldt, Bjarne W. Kristensen, Felix Sahm, Wenche Sjursen and Sverre H. Torp 
246 3 0 |a two 
264 1 |c 12 March 2021 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.08.2021 
520 |a Background: Due to the solely subjective histopathological assessment, the WHO 2016 classification of human meningiomas is subject to interobserver variation. Consequently, the need for more reliable and objective markers are highly needed. The aim of this pilot study was to apply genome-wide DNA methylation analysis on a series of atypical meningiomas to evaluate the practical utility of this approach, examine whether prognostic subclasses are achieved and investigate whether there is an association between the methylation subclasses with poor prognosis and time to recurrence. NF1/2 mutation analyses were also performed to explore the prognostic value of such mutations in these atypical meningiomas. Methods: Twenty intracranial WHO grade II atypical meningiomas from adult patients were included. They consisted of 10 cases with recurrence (group I), and 10 cases without recurrence (group II). The formalin-fixed and paraffin-embedded tissues underwent standardized genome-wide DNA methylation analysis, and the profiles were matched with the reference library and tumor classifier from Heidelberg. NF1/2 somatic mutation analyses were performed using the CNSv1panel from Düsseldorf. Results: Eighteen out of 20 cases matched to the meningioma class using the common brain tumor classifier (v11b4). Four of these cases matched to a methylation subclass related to a prognostic subgroup based on a cut-off of 0.9. NF2 mutations were detected in 55% of cases across both groups, and the most prominent copy number alterations were chromosomal losses of 22q, 1p and 14q. No significant NF1 mutations were identified. Conclusions: Genome-wide DNA methylation profiling represents a useful tool in the diagnostics of meningiomas, however, methodological adjustments need to be addressed. 
650 4 |a brain tumors 
650 4 |a diagnosis 
650 4 |a meningiomas 
650 4 |a methylation profiling 
650 4 |a molecular genetics 
650 4 |a prognosis 
700 1 |a Boldt, Henning B.  |e VerfasserIn  |4 aut 
700 1 |a Kristensen, Bjarne W.  |e VerfasserIn  |4 aut 
700 1 |a Sahm, Felix  |d 1984-  |e VerfasserIn  |0 (DE-588)1022852132  |0 (DE-627)717318478  |0 (DE-576)366075020  |4 aut 
700 1 |a Sjursen, Wenche  |e VerfasserIn  |4 aut 
700 1 |a Torp, Sverre H.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Cancers  |d Basel : MDPI, 2009  |g 13(2021), 6, Artikel-ID 1262, Seite 1-13  |h Online-Ressource  |w (DE-627)614095670  |w (DE-600)2527080-1  |w (DE-576)313958548  |x 2072-6694  |7 nnas  |a The prognostic value of methylation signatures and NF2 mutations in atypical meningiomas 
773 1 8 |g volume:13  |g year:2021  |g number:6  |g elocationid:1262  |g pages:1-13  |g extent:13  |a The prognostic value of methylation signatures and NF2 mutations in atypical meningiomas 
856 4 0 |u https://doi.org/10.3390/cancers13061262  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2072-6694/13/6/1262  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210428 
993 |a Article 
994 |a 2021 
998 |g 1022852132  |a Sahm, Felix  |m 1022852132:Sahm, Felix  |d 910000  |d 912000  |d 50000  |e 910000PS1022852132  |e 912000PS1022852132  |e 50000PS1022852132  |k 0/910000/  |k 1/910000/912000/  |k 0/50000/  |p 4 
999 |a KXP-PPN1756261148  |e 3918753700 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1756261148"],"doi":["10.3390/cancers13061262"]},"name":{"displayForm":["Rahmina Meta, Henning B. Boldt, Bjarne W. Kristensen, Felix Sahm, Wenche Sjursen and Sverre H. Torp"]},"note":["Gesehen am 03.08.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"title":"The prognostic value of methylation signatures and NF2 mutations in atypical meningiomas","title_sort":"prognostic value of methylation signatures and NF2 mutations in atypical meningiomas"}],"person":[{"display":"Meta, Rahmina","given":"Rahmina","role":"aut","family":"Meta"},{"display":"Boldt, Henning B.","family":"Boldt","given":"Henning B.","role":"aut"},{"role":"aut","given":"Bjarne W.","family":"Kristensen","display":"Kristensen, Bjarne W."},{"display":"Sahm, Felix","role":"aut","given":"Felix","family":"Sahm"},{"display":"Sjursen, Wenche","given":"Wenche","role":"aut","family":"Sjursen"},{"display":"Torp, Sverre H.","family":"Torp","role":"aut","given":"Sverre H."}],"relHost":[{"pubHistory":["1.2009 -"],"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"part":{"year":"2021","volume":"13","pages":"1-13","issue":"6","extent":"13","text":"13(2021), 6, Artikel-ID 1262, Seite 1-13"},"id":{"eki":["614095670"],"issn":["2072-6694"],"zdb":["2527080-1"]},"origin":[{"publisherPlace":"Basel","dateIssuedKey":"2009","dateIssuedDisp":"2009-","publisher":"MDPI"}],"note":["Gesehen am 27.05.2020"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"Cancers","title_sort":"Cancers"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"614095670","disp":"The prognostic value of methylation signatures and NF2 mutations in atypical meningiomasCancers"}],"origin":[{"dateIssuedDisp":"12 March 2021","dateIssuedKey":"2021"}],"physDesc":[{"extent":"13 S."}],"recId":"1756261148"} 
SRT |a METARAHMINPROGNOSTIC1220